Insights

Global Expansion Grünenthal's presence in 28 countries across Europe, Latin America, and the US, along with products available in approximately 100 countries, presents significant opportunities for partners to distribute and localize innovative pain management solutions in diverse markets.

Strategic Acquisitions The company's recent acquisition of Valinor Pharma and Movantik for $250 million indicates an openness to expanding its portfolio and entering new therapeutic segments, offering avenues for collaborations in opioid management and related pain therapies.

Investments in Manufacturing Grünenthal's substantial investment of over €87 million into Latin American manufacturing facilities signals capacity expansion and infrastructure development, creating potential for partners to supply raw materials, manufacturing tech, or distribution support.

Innovative Research Focus As a science-driven organization with collaborations like Catalent, Grünenthal’s focus on pipeline development in small molecule pain treatments offers opportunities for research partnerships, licensing, or supply chain enhancements.

Financial Scale and Growth With revenues around €1.8 billion and a strong global footprint, Grünenthal provides a substantial platform for business partners to explore joint ventures, co-marketing arrangements, or technology licensing in pain management innovations.

Grünenthal Group Tech Stack

Grünenthal Group uses 8 technology products and services including SAP, Articulate 360, Veeva Vault, and more. Explore Grünenthal Group's tech stack below.

  • SAP
    Customer Relationship Management
  • Articulate 360
    Education Management
  • Veeva Vault
    Enterprise Content Management
  • Ganglia
    IT Infrastructure Monitoring
  • Salesforce Marketing Cloud
    Marketing Performance Measurement
  • SAP Concur
    Travel And Expense Management
  • VMware
    Virtualisation Software
  • Minitab
    Visualisation Software

Media & News

Grünenthal Group's Email Address Formats

Grünenthal Group uses at least 1 format(s):
Grünenthal Group Email FormatsExamplePercentage
First.Last@grunenthal.comJohn.Doe@grunenthal.com
91%
First.Middle@grunenthal.comJohn.Michael@grunenthal.com
5%
Last.First@grunenthal.comDoe.John@grunenthal.com
3%
FirLast@grunenthal.comJohDoe@grunenthal.com
1%

Frequently Asked Questions

What is Grünenthal Group's phone number?

Minus sign iconPlus sign icon
You can contact Grünenthal Group's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Grünenthal Group's official website and social media links?

Minus sign iconPlus sign icon
Grünenthal Group's official website is grunenthal.com and has social profiles on LinkedInCrunchbase.

What is Grünenthal Group's NAICS code?

Minus sign iconPlus sign icon
Grünenthal Group's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Grünenthal Group have currently?

Minus sign iconPlus sign icon
As of December 2025, Grünenthal Group has approximately 4.6K employees across 4 continents, including EuropeSouth AmericaNorth America. Key team members include Cio: A. G.Chief Commercial Officer And Member Of The Corporate Executive Board: J. A.Chief Integration Officer Valinor Pharma Us: C. S.. Explore Grünenthal Group's employee directory with LeadIQ.

What industry does Grünenthal Group belong to?

Minus sign iconPlus sign icon
Grünenthal Group operates in the Pharmaceutical Manufacturing industry.

What technology does Grünenthal Group use?

Minus sign iconPlus sign icon
Grünenthal Group's tech stack includes SAPArticulate 360Veeva VaultGangliaSalesforce Marketing CloudSAP ConcurVMwareMinitab.

What is Grünenthal Group's email format?

Minus sign iconPlus sign icon
Grünenthal Group's email format typically follows the pattern of First.Last@grunenthal.com. Find more Grünenthal Group email formats with LeadIQ.

When was Grünenthal Group founded?

Minus sign iconPlus sign icon
Grünenthal Group was founded in 1946.

Grünenthal Group

Pharmaceutical ManufacturingNorth Rhine-westphalia, Germany1001-5000 Employees

Grünenthal is a global leader in pain management and related diseases. As a science-based, fully-integrated pharmaceutical company, we have a long track record of bringing innovative treatments and state-of-the-art technologies to patients worldwide. Our purpose is to change lives for the better – and innovation is our passion. We are focusing all of our activities and efforts on working towards our vision of a world free of pain.

Grünenthal is headquartered in Aachen, Germany, and has affiliates in 28 countries across Europe, Latin America and the US. Our products are available in approx. 100 countries. In 2024, Grünenthal employed around 4,300 people and achieved revenues of € 1.8 bn.

More Information on www.grunenthal.com 

Jobs & Career: http://careers.grunenthal.com/

Imprint: https://www.grunenthal.com/en/footer-links/imprint

Privacy: https://www.grunenthal.com/en/footer-links/privacy-statement-social-media

This company profile is managed by Global Communications. 

In our commitment to transparency and the principles outlined in our digital ethics charter, Grünenthal wishes to inform you that generative artificial intelligence technologies are occasionally used to enhance content on this channel. Each content piece has been reviewed and edited by a team member before publication to ensure accuracy.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1946
Employees
1001-5000

Section iconFunding & Financials

  • $10B

    Grünenthal Group's revenue is estimated to be in the range of $10B

Section iconFunding & Financials

  • $10B

    Grünenthal Group's revenue is estimated to be in the range of $10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.